NEOTHERAPEUTICS (NEOT) (NEOTW) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)

NEOT 1.919

+4.3%

Jan 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: john jansen who wrote (690)	6/22/1999 8:35:00 PM
From: NeuroInvestment	Read Replies (1) of 705

The FDA does not publically "comment" about any clinical trials. And I doubt there will be much private discussion between NEOT and the FDA until the 400 pt Phase 2b is completed, and analyzed (1Q:2000). At that point, NEOT will meet with them to discuss the design of a Phase III, assuming positive results in Ph2b. It is possible some preliminary talks could be held regarding trial design, but nothing that will reach the public, or influence the stock price. NeuroInvestment (www.neuroinvestment.com)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next